AJR AJR-based Continuing Ed for Technologists
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rivard, D. C.
Right arrow Articles by Lowe, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivard, D. C.
Right arrow Articles by Lowe, L. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.07.7002
AJR 2008; 190:S46-S52
© American Roentgen Ray Society


AJR Integrative Imaging LIFELONG LEARNING FOR RADIOLOGY

Radiological Reasoning: Multiple Hepatic Masses in an Infant

Douglas C. Rivard1 and Lisa H. Lowe1

1 Both authors: Department of Radiology, Children's Mercy Hospitals and Clinics and the University of Missouri–Kansas City, 2401 Gillham Rd., Kansas City, MO 64108.

Received April 19, 2007; accepted after revision June 11, 2007.

Address correspondence to D. C. Rivard (dcrivard{at}cmh.edu).

Keywords: hepatic hemangioma • hepatic masses • neuroblastoma • pediatric imaging

OBJECTIVE

A 4.5-month-old boy was found to have hepatomegaly by his primary care pediatrician on a routine well-baby check and was referred for sonography. Innumerable hepatic lesions of varying echogenicity were found in an enlarged liver. Further characterization with multiphase CT, followed by contrast-enhanced MRI, showed innumerable hepatic masses of varying size with heterogeneous enhancement. The objective of this article is to discuss appropriate evaluation of multiple hepatic masses in infants and describe the major disease entities that are considered in the differential diagnosis.

CONCLUSION

Hepatic lesions in infants frequently are evaluated with multiple imaging techniques in an attempt to identify imaging findings that would suggest a specific diagnosis. Although various imaging features may suggest a particular pathologic diagnosis, correlation with patient's age and laboratory markers often is the most helpful factor in infants to suggest a particular disease process and formulate a management plan.

Case History
A 4.5-month-old boy was evaluated on a routine well-baby check by his primary care physician, at which time the liver margin was palpated several centimeters below the right costal margin. The child had no known medical problems and was born full-term in an uncomplicated delivery. The patient had elevated levels of {alpha}-fetoprotein of 172 ng/mL (reference value, 0–7 ng/mL) and lactate dehydrogenase of 1,828 U/L (reference value, 425–975 U/L). Abdominal sonography was requested.

Sonography
Sonography showed hepatomegaly with diffuse discrete round hypoechoic and isoechoic lesions throughout the liver nearly replacing the normal parenchyma (Figs. 1A, 1B, and 1C). Doppler sonography suggested the lesions had mildly increased flow. The portal veins, hepatic veins, hepatic arteries, aorta, and inferior vena cava were normal, with little mass effect by the extensive hepatic lesions.


Figure 1
View larger version (103K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A Metastatic neuroblastoma in 4.5-month-old boy with hepatomegaly. Transverse sonogram of abdomen shows enlarged liver infiltrated with multiple heterogeneous masses of varying echogenicity.

 

Figure 2
View larger version (121K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B Metastatic neuroblastoma in 4.5-month-old boy with hepatomegaly. Coronal contrast-enhanced CT scan shows heterogeneously enhancing masses in enlarged liver. Also note subcutaneous nodule over right abdomen (arrow).

 

Figure 3
View larger version (103K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1C Metastatic neuroblastoma in 4.5-month-old boy with hepatomegaly. Axial contrast-enhanced T1-weighted MR image reveals innumerable masses in liver with varying degrees of enhancement.

 
Multiphase Contrast-Enhanced CT
Multiphase CT (unenhanced and contrast-enhanced arterial and venous phases) of the abdomen revealed discrete areas of low attenuation throughout the liver parenchyma before contrast administration. After contrast administration, the lesions had varying degrees of enhancement in the arterial phase. Because of the rapid equilibrium of contrast enhancement between the lesions and the normal liver parenchyma on the portal venous phase of the CT scan, the lesions were no longer visible. A left adrenal mass with compression of the anterior left kidney also was seen, in addition to several subcutaneous soft-tissue nodules scattered over the abdominal and chest walls. The right kidney was normal.

MRI
Multiplanar MR sequences were performed including T1-weighted, fat-saturated T2-weighted, inversion recovery, and dynamic contrast-enhanced T1-weighted images. Innumerable small round masses with overall increased T2 signal intensity and heterogeneous enhancement were present throughout an enlarged liver. The dynamic contrast-enhanced T1-weighted MR images showed varying heterogeneous peripheral and central enhancement in the lesions, with some completely filling in after a short delay.

Expert Discussion (Dr. Lowe)
The incidental discovery of hepatomegaly or a palpable right upper quadrant mass on physical examination, such as in this patient, should prompt additional imaging and laboratory workup. Indeed, organomegaly is one of the most common presentations of liver masses in infants [1]. Sonography is the initial imaging technique of choice because of its safety, expedience, and ability to provide general hepatic and abdominal information. The sonographic findings are extremely useful for planning an appropriate imaging evaluation. CT, MRI, nuclear scintigraphy, or a combination of studies with specified protocols appropriate to the suspected disorder can be suggested on the basis of the sonographic findings.

The differential diagnosis of hepatomegaly in infants is extensive. Benign causes include congestive heart failure, hepatitis, infantile hemangioma (also termed "hemangiomatosis" when multiple), infantile hemangioendothelioma, and mesenchymal hamartoma [1, 2]. The most common malignant hepatic lesions in infants are hepatoblastoma, metastatic disease (especially neuroblastoma and Wilms' tumor), and lymphoproliferative disorders (lymphoma or leukemia). Hepato megaly may also be the result of infectious disorders such as cat-scratch disease, pyogenic abscesses, fungal infection, and granulomatous disease [35].

The differential diagnosis can be narrowed by correlation with patient history (age at presentation), physical examination, laboratory values, and the distribution of other involved organs. The history and physical examination can usually exclude infectious or cardiac causes. The age of the patient at presentation helps immensely to limit the differential possibilities. Specifically, multiple hepatic lesions in an infant younger than 3 months are most likely to be infantile hepatic hemangiomas, which nearly always present before 6 months of age [6, 7]. Multiple hepatic lesions found in an infant older than 6 months are more likely due to metastatic disease. The young age of the patient in this case and the multiplicity of lesions scattered throughout the liver strongly suggest metastatic neuroblastoma or multiple infantile hemangiomas (hemangiomatosis) as the most likely diagnoses.

Laboratory Values
The presence of abnormal laboratory values, including catecholamines and elevated {alpha}-fetoprotein, may be useful. Urine catecholamines are elevated in more than 90% of neuroblastomas [8]. Their measurement is so pivotal in infants with multiple hepatic masses that catecholamine measurement should precede any imaging evaluation beyond sonography. The primary catecholamines excreted in patients with neuroblastoma are homovanillic acid (HVA) and vanillylmandelic acid (VMA). The sensitivity and specificity of HVA for detection of neuroblastoma are 72% and 98%, respectively [9]. Corresponding statistics for VMA are 80% sensitivity and 97% specificity [9].


Figure 4
View larger version (94K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2A Companion case. Multiple hepatic hemangiomas (hemangiomatosis) in 2-month-old boy with hepatomegaly. Axial unenhanced CT image reveals numerous low-attenuation areas scattered throughout liver.

 


Figure 5
View larger version (113K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2B Companion case. Multiple hepatic hemangiomas (hemangiomatosis) in 2-month-old boy with hepatomegaly. Axial contrast-enhanced CT scan shows vigorous homogeneous enhancement of lesions, confirming their vascular nature.

 


Figure 6
View larger version (105K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3 Companion case. Hemangioendothelioma in 2-year-old boy with hepatomegaly. Axial contrast-enhanced CT scan shows large mass in right lobe of liver with scattered calcifications (arrows); thick rind of heterogeneous, mostly peripheral enhancement; and central necrosis.

 
Distinction between infantile hemangiomas and neuroblastoma with imaging can be difficult. In many cases, a great deal of time, expense, and energy are spent on this impossible task when a simple urine screen for catecholamines may be diagnostic. Elevated urine catecholamines indicate metastatic neuroblastoma, and all further imaging can be directed to appropriate staging. Comparatively, the lack of catecholamines makes infantile hemangiomatosis more likely, and a careful conservative management approach is indicated.

Elevation of {alpha}-fetoprotein, however, should be considered with caution. Alpha-fetoprotein levels can vary greatly in neonates, with marked elevation immediately after birth and a gradual decline to normal levels over the first few months of life. As a general rule, {alpha}-fetoprotein levels decrease as gestation advances and birth weight increases [10]. Finally, the number of lesions and other associated organs involved can aid in narrowing the differential diagnosis. Hepatic hemangiomas are multiple in 10–20% of cases, and involvement of three or more organ systems is termed "disseminated hemangiomatosis" [11].

Differential Diagnosis
Vasoproliferative Disorders
Infantile hemangioma (or hemangiomatosis), the most common tumor in infants, has undergone a continuing evolution of understanding and reclassification over the past two to three decades (Figs. 2A and 2B). It is currently considered to be part of a spectrum of vasoproliferative disorders, which range from the benign infantile hemangioma to the intermediate lesion, hemangioendothelioma, to the rare malignant angiosarcoma [12]. Vasoproliferative lesions are diagnosed definitively with pathology and classified according to the binary system set forth by Mulliken [13] and Mulliken and Glowacki [14], which has gradually gained acceptance.

Histologically, hemangiomas are characterized by a rapidly dividing single layer of endothelial cells with an increase in mast cells during the regression phase. Recently, strong expression of the immunohistochemical marker, glucose transporter protein isoform-1 (GLUT1), has been described in infantile hemangiomas and is useful for a more definitive diagnosis [15].


Figure 7
View larger version (103K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4A Companion case. Angiosarcoma in 2-year-old girl with hepatomegaly. Transverse contrast-enhanced CT scan shows poorly defined, heterogeneously enhancing mass.

 


Figure 8
View larger version (106K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4B Companion case. Angiosarcoma in 2-year-old girl with hepatomegaly. Axial fat-suppressed contrast-enhanced T1-weighted MR image confirms infiltrative enhancing right hepatic mass in liver. Several other similar-appearing hepatic lesions were also found in liver (not shown).

 


Figure 9
View larger version (124K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5 Companion case. Metastatic Wilms' tumor in 4-year-old boy. Axial contrast-enhanced CT scan shows multiple, variably sized, low-attenuation masses (arrowheads) scattered throughout liver. Primary exophytic hetero geneous left renal Wilms' tumor (arrow) is also noted.

 
Clinically, hemangiomas follow a typical course, including an initial proliferative phase (usually during the first year of life), followed by gradual spontaneous involution over a period of months to years [16, 17]. By adolescence, most have undergone complete regression. Most hemangiomas are treated conservatively with careful observation. Occasionally, medical treatment (usually steroids) and, rarely, surgical treatment are required. However, complications of hemangiomas may arise if they impinge on vital structures (i.e., the nose, mouth, orbital globes) or become large enough to cause mass effect (severe hepatomegaly with respiratory symptoms), clinically significant arteriovenous shunting (may lead to heart failure), or coagulopathy due to intralesional hemorrhage/thrombosis/platelet sequestration [16, 18]. Recently, extensive hemangiomas have been associated with clinically significant hypothyroidism as well [19, 20].

Hemangioendothelioma occasionally has diffuse liver involvement, causing some overlap in the imaging appearance with infantile hemangiomas [21]. However, hemangioendotheliomas have a tendency toward a large single mass rather than the multiple small masses seen with infantile hemangiomas (Fig. 3). The distinction between these two vasoproliferative disorders is ultimately histologic, with hemangioendothelioma having slightly more aggressive features than hemangioma, including multiple layers of rapidly dividing endothelial cells with areas of hematopoiesis, hemorrhage, or necrosis [2, 21]. Both hemangioendotheliomas and hemangiomas have a favorable prognosis and typically regress without surgical or medical intervention [12]. Both have similar potential complications as well.

Angiosarcoma, a rare, highly malignant vasoproliferative hepatic lesion, may also present with multiple hepatic masses. It is diagnosed histologically on the basis of the presence of aggressive features [22, 23]. The imaging features of angiosarcomas are variable, but they tend to have multiple, large, well-defined masses with varying enhancement, central necrosis, and hemorrhage (Figs. 4A and 4B). The prognosis of angiosarcoma is extremely poor, with a 6- to 13-month median survival [24].

Hepatic Neoplasms
Pediatric hepatic masses account for 5–6% of all abdominal masses and 0.5–2% are malignant [25, 26]. The two most common malignant hepatic masses in children are metastases secondary to neuroblastoma and Wilms' tumor, which occur in up to 15% and 12% of patients, respectively [3, 4]. The most common primary pediatric hepatic malignancy is hepatoblastoma, which usually has a large single mass.


Figure 10
View larger version (97K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6A Companion case. Mycobacterium avium-intracellulare infection in 8-year-old boy with fever and abdominal pain. Axial contrast-enhanced CT scan shows multiple low-attenuation lesions (arrow) in liver and additional low-attenuation focus (arrowhead) in spleen.

 


Figure 11
View larger version (75K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6B Companion case. Mycobacterium avium-intracellulare infection in 8-year-old boy with fever and abdominal pain. Axial contrast-enhanced CT scan using bone algorithm shows isolated destructive lesion (arrow) of right posterior seventh rib.

 
Neuroblastoma is the third most common pediatric neoplasm after leukemia and intracranial tumors [8]. It arises in the neural crest cells of the adrenal gland or anywhere along the sympathetic nervous chain from skull base to sacrum. A palpable mass or abdominal distention is the presenting complaint in about half of all neuroblastoma patients [4]. Although nonspecific, abdominal pain is the most common presenting symptom [8]. Fifty percent of patients with neuroblastoma present before the age of 2 years, compared with infantile hemangiomas, which usually are present at or shortly after birth [8]. As mentioned previously, urine catecholamines acid (VMA and HVA) are isolated from the urine in more than 90% of patients with neuroblastoma [4].

Metastatic hepatic neuroblastoma has several imaging appearances depending on the type of involvement (multiple focal lesions vs diffuse infiltration or both). In the setting of multiple discrete focal masses, the sonographic echogenicity varies among lesions from hypo- to hyperechoic with varying color Doppler flow. On CT, multifocal liver lesions of low attenuation are identified, usually with diminished enhancement relative to the surrounding liver parenchyma. The liver also may become diffusely infiltrated with neuroblastoma, especially in stage 4s disease, which is defined as a primary tumor in an infant with dissemination to the liver, skin, or bone marrow [8]. Diffuse hepatic parenchymal infiltration may cause loss of normal hepatic architecture and often is associated with severe hepatomegaly. Diffuse heterogeneous hepatic echogenicity and contrast enhancement are seen on sonography and CT, respectively. On MRI, metastatic neuroblastoma typically appears hypointense on T1- and inhomogeneously hyperintense on T2-weighted sequences. Contrast-enhanced T1-weighted sequences show varying enhancement. Treatment involves lesion resection, chemotherapy, or both.

Wilms' Tumor
Wilms' tumor, together with neuroblastoma, is the most common hepatic metastasis in children. Wilms' tumor metastases occur to the lung most often (85% of cases), followed by the liver and lymph nodes [3, 27, 28]. These lesions have a variable appearance at imaging, with irregular complex mixed-density components and varying enhancement on CT and MRI (Fig. 5).

Lymphoproliferative Disorders
Lymphoproliferative disorders, such as leukemia and lymphoma, frequently involve the liver, but often are not seen with imaging despite being detected at autopsy [5, 2931]. With many metastatic lesions, extrahepatic masses or nodes are often present [32]. Multifocal disease is common, and the overall hepatic enlargement usually is not as severe as is seen in metastatic neuroblastoma [33].

Hepatic Infection
Multifocal liver abnormalities also can be seen in the setting of infectious processes such as cat-scratch disease or Mycobacterium avium-intracellulare infection [3436]. The history and physical findings in these patients usually are helpful in elucidating the cause. Infectious processes tend to be disseminated, and adenopathy and other signs of systemic infection are frequently present [37]. Extrahepatic lesions involving the spleen and lymph nodes also are an important diagnostic clue to the presence of infectious processes. Occasionally, a tissue specimen from a liver lesion or lymph node is required for diagnosis.

Other infectious disorders that may involve the liver include pyogenic abscess, fungal infection, and granulomatous disease [36]. Pyogenic abscesses most commonly are associated with biliary obstruction or cholangitis, and Staphylococcus aureus is the most commonly isolated organism [37]. Catscratch disease is a self-limited disorder caused by Bartonella henselae that most often affects the lymph nodes, but may involve any part of the reticuloendothelial system (liver, spleen, bone marrow) or brain parenchyma [36]. Hepatic candidiasis is a common cause of multiple hepatic and splenic lesions in immunocompromised patients [36]. Mycobacterial infection of the liver and spleen is most common in disseminated miliary pulmonary tuberculosis (> 80% of cases at autopsy) [37]. Hepatomegaly, and less often, focal macronodular liver lesions with or without calcifications, may be seen on sonography or CT (Figs. 6A and 6B). Nonspecific findings are seen on MRI, including focal lesions of low attenuation on T1-weighted and of bright signal on T2-weighted sequences. Lymphadenopathy with central low attenuation and a rim of peripheral enhancement is common [37].

Commentary
In the case presented, 24-hour urine was strongly positive for catecholamines, and a subsequent skin nodule biopsy confirmed the diagnosis of metastatic neuroblastoma, accounting for the multiple liver masses. Unfortunately, by the time the urine was checked, the patient already had undergone multiple radiologic studies in an attempt to reach a diagnosis.

Astute clinicians will undertake a concurrent laboratory and imaging evaluation in any child presenting with a liver mass. If the presence of elevated urine catecholamines or serum {alpha}-fetoprotein is detected, confirming the presence of neuroblastoma or suggesting hepatoblastoma, then further imaging can be selectively tailored to staging and surgical planning. Pathologic diagnosis or strong suggestion of a specific imaging diagnosis is important to determine treatment planning, which may be widely divergent depending on the diagnosis. Specifically, vasoproliferative disorders typically require no surgical or medical treatment, whereas neoplasms usually warrant intensive medical or surgical treatment. Despite correlation of clinical presentation, age, laboratory values, and imaging, biopsy is ultimately required for a pathologic diagnosis in some patients.

References

  1. Chang HC, Nguyen B, Regan F. Hepatomegaly and multiple liver lesions. Postgrad Med J 1998;74 : 439-440[Free Full Text]
  2. DeMatteo RP, Fong Y. Imaging of hepatobiliary neoplasms. Surg Oncol Clin N Am 1999;8 : 59-89[Medline]
  3. Cohen MD, Siddiqui A. Liver metastases in Wilms' tumour. Clin Radiol 1982;33 : 539-540[CrossRef][Medline]
  4. David R, Lamki N, Fan S, et al. The many faces of neuroblastoma. RadioGraphics 1989;9 : 859-882[Abstract]
  5. Kuroda J, Omoto A, Fujiki H, et al. Primary hepatic Burkitt's lymphoma with chronic hepatitis C. Acta Haematol2001; 105:237 -240[CrossRef][Medline]
  6. Boon LM, Burrows PE, Paltiel HJ, et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr1996; 129:346 -354[CrossRef][Medline]
  7. Iyer CP, Stanley P, Mahour GH. Hepatic hemangiomas in infants and children: a review of 30 cases. Am Surg1996; 62:356 -360[Medline]
  8. Lonergan GJ, Schwab CM, Suarez ES, Carlson CL. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic–pathologic correlation. RadioGraphics 2002;22 : 911-934[Abstract/Free Full Text]
  9. Horsmans Y, Desager JP, Harvengt C. Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children [in French]. Bull Cancer 1990; 77:985 -989[Medline]
  10. Bader D, Riskin A, Vafsi O, et al. Alpha-fetoprotein in the early neonatal period—a large study and review of the literature. Clin Chim Acta 2004;349 : 15-23[CrossRef][Medline]
  11. Powers C, Ros PR, Stoupis C, Johnson WK, Segel KH. Primary liver neoplasms: MR imaging with pathologic correlation. RadioGraphics 1994;14 : 459-482[Abstract]
  12. Burrows PE, Dubois J, Kassarjian A. Pediatric hepatic vascular anomalies. Pediatr Radiol 2001;31 : 533-545[Medline]
  13. Mulliken JB. A biologic approach to cutaneous vascular anomalies. Pediatr Dermatol 1992;9 : 356-357[Medline]
  14. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69 : 412-422[Medline]
  15. Leon-Villapalos J, Wolfe K, Kangesu L. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 2005;58 : 348-352[CrossRef][Medline]
  16. Kassarjian A, Zurakowski D, Dubois J, Paltiel HJ, Fishman SJ, Burrows PE. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR 2004;182 : 785-795[Abstract/Free Full Text]
  17. Dubois J, Garel L. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr Radiol 1999; 29:879 -893[CrossRef][Medline]
  18. Miller T, Frieden IJ. Hemangiomas: new insights and classification. Pediatr Ann 2005;34 : 179-187[Medline]
  19. Lee TC, Barshes NR, Agee EE, et al. Resolution of medically resistant hypothyroidism after liver transplantation for hepatic hemangioendothelioma. J Pediatr Surg2006; 41:1783 -1785[CrossRef][Medline]
  20. Ho J, Kendrick V, Dewey D, Pacaud D. New insight into the pathophysiology of severe hypothyroidism in an infant with multiple hepatic hemangiomas. J Pediatr Endocrinol Metab2005; 18:511 -514[Medline]
  21. Han SJ, Tsai CC, Tsai HM, Chen YJ. Infantile hemangioendothelioma with a highly elevated serum alpha-fetoprotein level. Hepatogastroenterology 1998;45 : 459-461[Medline]
  22. Nord KM, Kandel J, Lefkowitch JH, et al. Multiple cutaneous infantile hemangiomas associated with hepatic angiosarcoma: case report and review of the literature. Pediatrics2006; 118:e907 -913[Abstract/Free Full Text]
  23. Dimashkieh HH, Mo JQ, Wyatt-Ashmead J, Collins MH. Pediatric hepatic angiosarcoma: case report and review of the literature. Pediatr Dev Pathol 2004;7 : 527-532[CrossRef][Medline]
  24. Awan S, Davenport M, Portmann B, Howard ER. Angiosarcoma of the liver in children. J Pediatr Surg 1996;31 : 1729-1732[CrossRef][Medline]
  25. Davey MS, Cohen MD. Imaging of gastrointestinal malignancy in childhood. Radiol Clin North Am 1996;34 : 717-742[Medline]
  26. Donnelly LF, Bisset GS 3rd. Pediatric hepatic imaging. Radiol Clin North Am 1998;36 : 413-427[CrossRef][Medline]
  27. Szavay P, Luithle T, Graf N, Furtwängler R, Fuchs J. Primary hepatic metastases in nephroblastoma—a report of the SIOP/GPOH Study. J Pediatr Surg 2006;41 : 168-172; discussion 168-172[CrossRef][Medline]
  28. Sripathi V, Muralidharan KV, Ramesh S, Muralinath S. Wilms' tumor with vena caval, atrial, and middle hepatic vein tumor thrombus. Pediatr Surg Int 2000;16 : 447-448[CrossRef][Medline]
  29. Broxson EH, Dole M, Wong R, Laya BF, Stork L. Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy. Pediatr Blood Cancer 2005;44 : 226-231[CrossRef][Medline]
  30. Fikri M, Dafiri R. Primary hepatic lymphoma: report of a pediatric case [in French]. J Radiol 2006;87 : 311-313[CrossRef][Medline]
  31. Salmon JS, Thompson MA, Arildsen RC, Greer JP. Non-Hodgkin's lymphoma involving the liver: clinical and therapeutic considerations. Clin Lymphoma Myeloma 2006;6 : 273-280[Medline]
  32. Carneiro RC, Fordham LA, Semelka RC. MR imaging of the pediatric liver. Magn Reson Imaging Clin N Am 2002;10 : 137-164[CrossRef][Medline]
  33. Lin PC, Chang TT, Jang RC, Chiou SS. Hepatosplenic microabscesses in pediatric leukemia: a report of five cases. Kaohsiung J Med Sci 2003; 19:368 -374[Medline]
  34. Abdel-Dayem HM, Omar WS, Aziz M, et al. Disseminated mycobacterium avium complex. Review of Ga-67 and TI-201 scans and autopsy findings. Clin Nucl Med 1996;21 : 547-556[CrossRef][Medline]
  35. Brizi MG, Celi G, Scaldazza AV, Barbaro B. Diagnostic imaging of abdominal tuberculosis: gastrointestinal tract, peritoneum, lymph nodes. Rays 1998; 23:115 -125[Medline]
  36. Lowe LH, Hernanz-Schulman M. Cat-scratch disease. In: Sty JR, ed.Pediatric Disease V syllabus . Reston, VA: American College of Radiology, 2002: 285-301
  37. Kawamoto S, Soyer PA, Fishman EK, Bluemke DA. Nonneoplastic liver disease: evaluation with CT and MR imaging. RadioGraphics 1998;18 : 827-848[Abstract]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
C.-H. Liu, D. C. Rivard, A. C. Silva, K. J. Burkholz, and S. D. Beaty
Imaging of Focal Hepatic Lesions: Self-Assessment Module
Am. J. Roentgenol., June 1, 2008; 190(6_Supplement): S65 - S68.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rivard, D. C.
Right arrow Articles by Lowe, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivard, D. C.
Right arrow Articles by Lowe, L. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS